Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.4550
+0.0200 (4.60%)
Mar 11, 2026, 4:10 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 125.79 million as of March 10, 2026. Its market cap has increased by 26.17% in one year.
Market Cap
125.79M
Enterprise Value
126.24M
Revenue
974.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 125.79M, an increase of 512.22%. That is a compound annual growth rate of 19.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 125.79M | -33.08% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 196.97M |
| Starpharma Holdings | 170.07M |
| Actinogen Medical | 150.18M |
| Botanix Pharmaceuticals | 126.43M |
| Island Pharmaceuticals | 123.80M |
| Paradigm Biopharmaceuticals | 112.01M |
| Arovella Therapeutics | 92.95M |
| LTR Pharma | 81.80M |